Rare diseases
Investigational molecules
Locations
A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
PolandA Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
PolandA Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies
PolandA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
PolandA Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
PolandComparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
PolandStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
PolandStudy of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis
PolandStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
PolandStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
PolandStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
PolandLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
